Weekly CEO News from Richard Ingram
May 1, 2017

The Chart of the Day belongs to Bio-Rad Laboratories (BIO). I found the medical products stock by using Barchart to sort today’s Top Stocks to Own list first for the most frequent number of new highs in the last month, then again for technical buy signals

Read more

The price of gold is dominated by investment demand* to such an extent that nothing else matters as far as its price performance is concerned. Investment demand is also the most important driver of silver’s price trend, although in silver’s

Read more

Podcast: Play in new window | Play in new window (Duration: 13:15 — 7.6MB) DOW – 27 = 20,913 SPX + 4 = 2388 NAS + 44 = 6091 RUT + 6 = 1407 10 Y + .04 = 2.32% OIL – .56 =

Read more

The Short-Term A new short-term up-trend started on April-20, but this up-trend might already be starting to falter.  The PMO index for the SPX looks like it might be topping out. New 52-week lows were a bit elevated today. It

Read more

In March, auto sales unexpectedly declined  5.7%.  Forecasts now suggest April will mark the fourth straight monthly decline in U.S. vehicle sales. Not to worry, Detroit Auto Makers Are Upbeat as Sales Volumes Stall. Industry observers say they don’t expect a

Read more

I can’t make any promises…time has been scarce as of late, but hoping to just post the chart today and give a more detailed analysis later. Looking at the month, revenues were solid and timing issues compared to last year brought

Read more

On Friday, the Dow Jones Industrial Average closed lower after the U.S. posted weak GDP data. Both the Chicago PMI and consumer sentiment was shown to edge higher. Those pieces of data is what likely kept the DOW from falling

Read more

ORLY has dropped about thirty dollars since I did this post last week. I suspect it has much further to go. ORLY used to beat the market handily, but now it’s, shall we say, underperforming (the boring old SPY is shown

Read more

Biotech Now Approaching Breakout Levels From February Tech and Biotech Lead the Market: Nasdaq up 0.73% to 6091.60 We expect a biotech breakout to 52 week highs in the coming months because of new products, good clinical news and M&A. Biotech has

Read more

uLong Micron Technology (MU) Long Magna International (MGA) Short Celanese (CE)